Rockwell Medical, Inc.

Equities

RMTI

US7743743004

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.455 USD -3.64% Intraday chart for Rockwell Medical, Inc. +0.34% -23.02%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States CI
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda CI
HC Wainwright Cuts Price Target on Rockwell Medical to $9 From $11, Keeps Buy Rating MT
Transcript : Rockwell Medical, Inc., Q4 2023 Earnings Call, Mar 21, 2024
(RMTI) ROCKWELL MEDICAL Expects Fiscal Year 2024 Revenue Range $84M - $88M MT
Earnings Flash (RMTI) ROCKWELL MEDICAL Posts Q4 Revenue $22.1M MT
Rockwell Medical, Inc. Provides Earnings Guidance for the Year 2024 CI
Rockwell Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (RMTI) ROCKWELL MEDICAL Reports Q4 EPS $0.02 MT
Rockwell Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Rockwell Medical, Inc. Provides Earnings Guidance for Fourth Quarter and Full-Year 2023 CI
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund CI
Transcript : Rockwell Medical, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (RMTI) ROCKWELL MEDICAL Reports Q3 Revenue $23.8M MT
Rockwell Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Rockwell Medical, Inc. Provides Financial Guidance for the Year 2023 CI
Rockwell Medical, Inc. Appoints Jesse Neri as Senior Vice President, Finance CI
Rockwell Medical, Inc. Appoints Joan Lau, Ph.D. to the Company's Board of Directors CI
Maxim Initiates Coverage on Rockwell Medical with Buy Rating, $5 Price Target MT
Rockwell Medical to be the Preferred Supplier of Hemodialysis Concentrates, Accessories to Centers for Dialysis Care MT
Rockwell Medical Signs Multi-Year Product Purchase Deal With Centers for Dialysis Care; Shares Climb Premarket MT
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care CI
Rockwell Medical to Supply Materials to Sanderling Renal Services Facilities MT
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services CI
Sector Update: Health Care Stocks Tick Lower Thursday Morning MT
Chart Rockwell Medical, Inc.
More charts
Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. It operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. Its first two branded products from its ferric pyrophosphate citrate (FPC) platform, Triferic (dialysate) and Triferic AVNU, are indicated to maintain hemoglobin in patients undergoing hemodialysis. It offers dry and liquid citric acid, acetic acid, and bicarbonate hemodialysis products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.455 USD
Average target price
7 USD
Spread / Average Target
+381.10%
Consensus
  1. Stock Market
  2. Equities
  3. RMTI Stock
  4. News Rockwell Medical, Inc.
  5. HC Wainwright Cuts Price Target on Rockwell Medical to $9 From $11, Keeps Buy Rating